# A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma

> **NCT02157636** · PHASE1 · COMPLETED · sponsor: **Constellation Pharmaceuticals** · enrollment: 30 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **DRUG:** CPI-0610

## Key facts

- **NCT ID:** NCT02157636
- **Lead sponsor:** Constellation Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-07-15
- **Primary completion:** 2016-11-08
- **Final completion:** 2016-11-08
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2024-04-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02157636

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02157636, "A Phase 1 Study Evaluating CPI-0610 in Patients With Previously Treated Multiple Myeloma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02157636. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*